Before treatment, each client completes a medical screening and consultation to determine suitability and personalize antioxidant support based on their wellness goals and health profile
MAN has participated in advisory boards or was invited as speaker by Amylin Pharmaceuticals, AstraZeneca, Berlin Chemie, Boehringer Ingelheim, Bristol-Myers Squibb, Diartis Pharmaceuticals, Inc., Eli Lilly & Co., GlaxoSmithKline, Hoffmann-La Roche Ltd, Intarcia Therapeutics, Inc., Janssen Global Services, MannKind Corp., Merck Sharp & Dohme GmbH, Novo Nordisk, Novartis, Sanofi-Aventis, Takeda, Versartis, Wyeth Research
Thats still substantial
While compounded medications are not FDA-approved in the traditional sense, 503A compounders must meet rigorous quality, sterility, and potency requirements, making them legitimate therapeutic options
Common mistakes that sabotage results Most failures in this combination come from predictable, avoidable errors